TNF and psoriasis: Indeed, a prospective study evaluating CFR in 37 consecutive patients with moderate to severe psoriasis before and after 6 months of treatment with TNF-α inhibitors reported a CFR increase from 2.2 ± 0.7 to 3.02 ± 0.8 (p<0.0001) (59).